Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Neoplasm Recurrence, Local"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 61614
Tytuł:
PAQR8 promotes breast cancer recurrence and confers resistance to multiple therapies.
Autorzy:
Chen S; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Room 614 BRB II/III, 421 Curie Boulevard, Philadelphia, PA, 19104-6160, USA.; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Paul MR; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Room 614 BRB II/III, 421 Curie Boulevard, Philadelphia, PA, 19104-6160, USA.; 2-PREVENT Translational Center of Excellence, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Sterner CJ; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Room 614 BRB II/III, 421 Curie Boulevard, Philadelphia, PA, 19104-6160, USA.; 2-PREVENT Translational Center of Excellence, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Belka GK; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Room 614 BRB II/III, 421 Curie Boulevard, Philadelphia, PA, 19104-6160, USA.; 2-PREVENT Translational Center of Excellence, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Wang D; Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Xu P; Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Sreekumar A; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Room 614 BRB II/III, 421 Curie Boulevard, Philadelphia, PA, 19104-6160, USA.; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Pan TC; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Room 614 BRB II/III, 421 Curie Boulevard, Philadelphia, PA, 19104-6160, USA.; 2-PREVENT Translational Center of Excellence, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Pant DK; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Room 614 BRB II/III, 421 Curie Boulevard, Philadelphia, PA, 19104-6160, USA.; 2-PREVENT Translational Center of Excellence, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Makhlin I; 2-PREVENT Translational Center of Excellence, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
DeMichele A; 2-PREVENT Translational Center of Excellence, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Mesaros C; Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Chodosh LA; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Room 614 BRB II/III, 421 Curie Boulevard, Philadelphia, PA, 19104-6160, USA. .; 2-PREVENT Translational Center of Excellence, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. .; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. .; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. .
Pokaż więcej
Źródło:
Breast cancer research : BCR [Breast Cancer Res] 2023 Jan 03; Vol. 25 (1), pp. 1. Date of Electronic Publication: 2023 Jan 03.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Resistance, Neoplasm*/genetics
Neoplasm Recurrence, Local*/genetics
Neoplasm Recurrence, Local*/pathology
Animals ; Mice ; Lapatinib ; Fulvestrant ; Receptor, ErbB-2/metabolism ; Estrogens ; Receptors, Progesterone
Czasopismo naukowe
Szczegóły
Tytuł:
Patterns of care for relapsed oesophageal cancer after initial curative trimodality therapy: Long-term follow-up of the SAKK 75/08 trial.
Autorzy:
Panje C; Department of Radiation Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Switzerland.
Hayoz S; Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland.
Eisterer W; Department for Internal Medicine and Hematology and Medical Oncology, Klinikum Klagenfurt a.W, Klagenfurt, Austria.
Hess V; Department of Medical Oncology; University Hospital of Basel, Basel, Switzerland.
Thuss-Patience P; Department of Hematology, Oncology, and Tumor Immunology, Charité-University Medicine Berlin, Campus Virchow-Klinikum, Berlin, Germany.
Schacher S; Department of Oncology, Kantonsspital Winterthur, Winterthur, Switzerland.
Dürr D; Department of Oncology, Stadtspital Triemli, Zürich, Switzerland.
Wagner AD; Department of Oncology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.
Girschikofsky M; Medical Oncology Internal Medicine I, Elisabethinen Hospital, Linz, Austria.
Eboulet E; Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland.
Stahl M; Department of Medical Oncology, Evang. Kliniken Essen-Mitte, Essen, Germany.
Ruhstaller T; Department of Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland; University of Basel, Basel, Switzerland. Electronic address: .
Pokaż więcej
Źródło:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Dec; Vol. 177, pp. 186-193. Date of Electronic Publication: 2022 Oct 05.
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neoplasm Recurrence, Local*/therapy
Neoplasm Recurrence, Local*/pathology
Esophageal Neoplasms*/therapy
Esophageal Neoplasms*/pathology
Humans ; Follow-Up Studies ; Esophagectomy ; Chemoradiotherapy
Czasopismo naukowe
Szczegóły
Tytuł:
Advanced and recurrent endometrial cancer: State of the art and future perspectives.
Autorzy:
Tronconi F; Oncologic Clinic, Università Politecnica delle Marche, Via Conca 71, 60126 Torrette, Ancona, Italy; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
Nero C; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
Giudice E; Institute of Obstetrics and Gynecology, Università Cattolica del Sacro Cuore, Roma, Largo Agostino Gemelli 8, 00168, Rome, Italy.
Salutari V; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
Musacchio L; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
Ricci C; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
Carbone MV; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
Ghizzoni V; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
Perri MT; Institute of Obstetrics and Gynecology, Università Cattolica del Sacro Cuore, Roma, Largo Agostino Gemelli 8, 00168, Rome, Italy.
Camarda F; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy; Medical Oncology, Università Cattolica del Sacro Cuore, Largo Agostino Gemelli 8, 00168, Rome, Italy.
Gentile M; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy; Medical Oncology, Azienda Ospedaliero Universitaria Consorziale Policlinico, Piazza Giulio Cesare 11, 70124 Bari, BA, Italy.
Berardi R; Oncologic Clinic, Università Politecnica delle Marche, Via Conca 71, 60126 Torrette, Ancona, Italy.
Scambia G; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy; Institute of Obstetrics and Gynecology, Università Cattolica del Sacro Cuore, Roma, Largo Agostino Gemelli 8, 00168, Rome, Italy.
Lorusso D; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy; Institute of Obstetrics and Gynecology, Università Cattolica del Sacro Cuore, Roma, Largo Agostino Gemelli 8, 00168, Rome, Italy. Electronic address: .
Pokaż więcej
Źródło:
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2022 Dec; Vol. 180, pp. 103851. Date of Electronic Publication: 2022 Oct 17.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Neoplasm Recurrence, Local*/drug therapy
Neoplasm Recurrence, Local*/genetics
Endometrial Neoplasms*/diagnosis
Endometrial Neoplasms*/drug therapy
Endometrial Neoplasms*/genetics
Female ; Humans ; Immunotherapy ; Microsatellite Instability
Czasopismo naukowe
Szczegóły
Tytuł:
Population-based study of treatment and outcome of recurrent oesophageal or junctional cancer.
Autorzy:
Pape M; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.; Department of Medical Oncology, Cancer Centre Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Vissers PAJ; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.; Department of Surgery, Radboud University Medical Centre, Nijmegen, the Netherlands.
Bertwistle D; Worldwide Health Economics and Outcomes Research, Bristol-Myers Squibb, Uxbridge, UK.
McDonald L; Centre for Observational Research and Data Sciences, Bristol-Myers Squibb, Uxbridge, UK.
Beerepoot LV; Department of Medical Oncology, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands.
van Berge Henegouwen MI; Department of Surgery, Cancer Centre Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Lagarde SM; Department of Surgery, Erasmus University Medical Centre, Rotterdam, the Netherlands.
Mook S; Department of Radiation Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.
Mohammad NH; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
Jeene PM; Department of Radiation Oncology, Amsterdam University Medical Centres, Amsterdam, the Netherlands.; Radiotherapiegroep, Deventer, the Netherlands.
van Laarhoven HWM; Department of Medical Oncology, Cancer Centre Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Verhoeven RHA; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.; Department of Medical Oncology, Cancer Centre Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Pokaż więcej
Źródło:
The British journal of surgery [Br J Surg] 2022 Nov 22; Vol. 109 (12), pp. 1264-1273.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/epidemiology
Neoplasm Recurrence, Local*/therapy
Neoplasm Recurrence, Local*/pathology
Esophageal Neoplasms*/therapy
Esophageal Neoplasms*/pathology
Humans ; Esophagectomy/methods ; Treatment Outcome ; Retrospective Studies
Czasopismo naukowe
Szczegóły
Tytuł:
Metastatic recurrence in colorectal cancer arises from residual EMP1 cells.
Autorzy:
Cañellas-Socias A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
Cortina C; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
Hernando-Momblona X; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
Palomo-Ponce S; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
Mulholland EJ; Gastrointestinal Stem Cell Biology Lab, Wellcome Centre Human Genetics, University of Oxford, Oxford, UK.
Turon G; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Mateo L; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Conti S; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Roman O; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Sevillano M; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
Slebe F; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Stork D; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Caballé-Mestres A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Berenguer-Llergo A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Álvarez-Varela A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
Fenderico N; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Novellasdemunt L; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Jiménez-Gracia L; CNAG-CRG, Centre for Genomic Regulation, The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Sipka T; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Bardia L; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Lorden P; CNAG-CRG, Centre for Genomic Regulation, The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Colombelli J; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Heyn H; CNAG-CRG, Centre for Genomic Regulation, The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Trepat X; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
Tejpar S; Digestive Oncology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
Sancho E; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
Tauriello DVF; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Leedham S; Gastrointestinal Stem Cell Biology Lab, Wellcome Centre Human Genetics, University of Oxford, Oxford, UK.; Translational Gastroenterology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK.; Oxford National Institute for Health Research Biomedical Research Centre, Oxford, UK.
Attolini CS; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Batlle E; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. .; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain. .; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. .
Pokaż więcej
Źródło:
Nature [Nature] 2022 Nov; Vol. 611 (7936), pp. 603-613. Date of Electronic Publication: 2022 Nov 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/metabolism
Colorectal Neoplasms*/pathology
Colorectal Neoplasms*/therapy
Neoplasm Proteins*/deficiency
Neoplasm Proteins*/genetics
Neoplasm Proteins*/metabolism
Neoplasm Recurrence, Local*/genetics
Neoplasm Recurrence, Local*/pathology
Neoplasm Recurrence, Local*/prevention & control
Neoplasm Recurrence, Local*/therapy
Neoplasm, Residual*/genetics
Neoplasm, Residual*/pathology
Receptors, Cell Surface*/deficiency
Receptors, Cell Surface*/genetics
Receptors, Cell Surface*/metabolism
Neoplasm Metastasis*/genetics
Neoplasm Metastasis*/pathology
Neoplasm Metastasis*/prevention & control
Neoplasm Metastasis*/therapy
Animals ; Humans ; Mice ; Disease Progression ; Disease Models, Animal ; T-Lymphocytes/cytology ; T-Lymphocytes/immunology ; Lymphocytes, Tumor-Infiltrating/cytology ; Lymphocytes, Tumor-Infiltrating/immunology ; Neoadjuvant Therapy ; Immunotherapy
Czasopismo naukowe
Szczegóły
Tytuł:
Additively manufactured Bi-functionalized bioceramics for reconstruction of bone tumor defects.
Autorzy:
Belluomo R; Department of Orthopedics, University Medical Center Utrecht, Utrecht 3508GA, the Netherlands.
Khodaei A; Department of Orthopedics, University Medical Center Utrecht, Utrecht 3508GA, the Netherlands.
Amin Yavari S; Department of Orthopedics, University Medical Center Utrecht, Utrecht 3508GA, the Netherlands; Regenerative Medicine Utrecht, Utrecht University, Utrecht, the Netherlands. Electronic address: .
Pokaż więcej
Źródło:
Acta biomaterialia [Acta Biomater] 2023 Jan 15; Vol. 156, pp. 234-249. Date of Electronic Publication: 2022 Aug 24.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Neoplasm Recurrence, Local*
Bone Neoplasms*/drug therapy
Humans ; Biocompatible Materials/pharmacology ; Bone and Bones ; Tissue Engineering/methods ; Bone Regeneration ; Ceramics/pharmacology ; Ceramics/therapeutic use ; Tumor Microenvironment
Czasopismo naukowe
Szczegóły
Tytuł:
Associations of muscle and adipose tissue parameters with long-term outcomes in middle and low rectal cancer: a retrospective cohort study.
Autorzy:
Liu J; Department of Radiology, Quanzhou First Hospital Affiliated to Fujian Medical University, 248-252 N, Dong Street, Quanzhou City, Fujian Province, China.
Yu X; Department of Radiology, Second Affiliated Hospital of Fujian Medical University, 34 N, Zhong-Shan-Bei Street, Quanzhou City, Fujian Province, China.
Huang X; Department of Radiology, Quanzhou First Hospital Affiliated to Fujian Medical University, 248-252 N, Dong Street, Quanzhou City, Fujian Province, China.
Lai Q; Department of Radiology, Second Affiliated Hospital of Fujian Medical University, 34 N, Zhong-Shan-Bei Street, Quanzhou City, Fujian Province, China. .
Chen J; Department of Radiology, Quanzhou First Hospital Affiliated to Fujian Medical University, 248-252 N, Dong Street, Quanzhou City, Fujian Province, China. .
Pokaż więcej
Źródło:
Cancer imaging : the official publication of the International Cancer Imaging Society [Cancer Imaging] 2023 Jan 12; Vol. 23 (1), pp. 5. Date of Electronic Publication: 2023 Jan 12.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/pathology
Rectal Neoplasms*/diagnostic imaging
Rectal Neoplasms*/surgery
Rectal Neoplasms*/pathology
Humans ; Male ; Female ; Retrospective Studies ; Reproducibility of Results ; Prognosis ; Muscle, Skeletal/diagnostic imaging ; Muscle, Skeletal/pathology ; Adipose Tissue/diagnostic imaging
Czasopismo naukowe
Szczegóły
Tytuł:
Digital Health Interventions for Adult Patients With Cancer Evaluated in Randomized Controlled Trials: Scoping Review.
Autorzy:
Lee K; College of Nursing, Konyang University, Daejeon, Republic of Korea.
Kim S; College of Nursing and Mo-im Kim Nursing Research Institute, Yonsei Evidence Based Nursing Center of Korea: Affiliation of the Joanna Briggs Institution, Yonsei University, Seoul, Republic of Korea.
Kim SH; Department of Nursing, Inha University, Inchon, Republic of Korea.
Yoo SH; College of Nursing, Chonnam National University, Gwangju, Republic of Korea.
Sung JH; College of Nursing, Kosin University, Busan, Republic of Korea.
Oh EG; College of Nursing and Mo-im Kim Nursing Research Institute, Yonsei Evidence Based Nursing Center of Korea: Affiliation of the Joanna Briggs Institution, Yonsei University, Seoul, Republic of Korea.
Kim N; Yonsei Medical Library, Yonsei University, Seoul, Republic of Korea.
Lee J; College of Nursing and Mo-im Kim Nursing Research Institute, Yonsei Evidence Based Nursing Center of Korea: Affiliation of the Joanna Briggs Institution, Yonsei University, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
Journal of medical Internet research [J Med Internet Res] 2023 Jan 06; Vol. 25, pp. e38333. Date of Electronic Publication: 2023 Jan 06.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Neoplasm Recurrence, Local*
Quality of Life*
Humans ; Aged ; Randomized Controlled Trials as Topic ; Anxiety/therapy ; Exercise
Czasopismo naukowe
Szczegóły
Tytuł:
Long-term outcomes of patients with conjunctival extranodal marginal zone lymphoma.
Autorzy:
Saul EE; Department of Internal Medicine, Jackson Memorial Hospital/University of Miami, Miller School of Medicine, Miami, Florida, USA.
Alderuccio JP; Division of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, Florida, USA.
Reis IM; Departmetn of Public Health Science, University of Miami, Miller School of Medicine, Miami, Florida, USA.; Division of Biostatistics, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, Florida, USA.
Zhao W; Division of Biostatistics, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, Florida, USA.
Iyer SG; Division of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, Florida, USA.
Rodriguez G; Division of Hematology-Oncology, Department of Medicine, University of Florida, Gainesville, Florida, USA.
Desai A; Department of Hematology-Oncology, OHSU Knight Cancer Institute, Oregon Health Sciences University, Portland, Oregon, USA.
Chapman JR; Department of Pathology, University of Miami, Miller School of Medicine, Miami, Florida, USA.
Tse DT; Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine, Miami, Florida, USA.
Markoe AM; Division of Radiation Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, Florida, USA.
Isrow DM; Division of Radiation Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, Florida, USA.
Lossos IS; Division of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, Florida, USA.
Pokaż więcej
Źródło:
American journal of hematology [Am J Hematol] 2023 Jan; Vol. 98 (1), pp. 148-158. Date of Electronic Publication: 2022 May 20.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*
Lymphoma, B-Cell, Marginal Zone*
Humans ; Female ; Middle Aged ; Male ; Disease-Free Survival ; Retrospective Studies ; Progression-Free Survival ; Prognosis
Czasopismo naukowe
Szczegóły
Tytuł:
Comments on: The clinical relevance of various methods of classifying ipsilateral breast tumor recurrence as either true local recurrence or new primary.
Autorzy:
Qu FL; Department of Breast Surgery, Fudan University Shanghai Cancer Center, No. 270 Dong-An Road, Xuhui District, Shanghai, 200032, People's Republic of China.; Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Li JJ; Department of Breast Surgery, Fudan University Shanghai Cancer Center, No. 270 Dong-An Road, Xuhui District, Shanghai, 200032, People's Republic of China.; Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Shao ZM; Department of Breast Surgery, Fudan University Shanghai Cancer Center, No. 270 Dong-An Road, Xuhui District, Shanghai, 200032, People's Republic of China. zhimin_.; Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. zhimin_.
Pokaż więcej
Źródło:
Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Jan; Vol. 197 (1), pp. 243-244. Date of Electronic Publication: 2022 Oct 30.
Typ publikacji:
Letter
MeSH Terms:
Neoplasm Recurrence, Local*/pathology
Breast Neoplasms*/diagnosis
Humans ; Female ; Clinical Relevance ; Breast/pathology ; Mastectomy, Segmental
Opinia redakcyjna
Szczegóły
Tytuł:
The application of antidepressant drugs in cancer treatment.
Autorzy:
Zheng Y; Department of Orthopedics, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China; Medical Collage of Nanchang University, Nanchang, Jiangxi 330006, China.
Chang X; Medical Collage of Nanchang University, Nanchang, Jiangxi 330006, China.
Huang Y; Medical Collage of Nanchang University, Nanchang, Jiangxi 330006, China.
He D; Department of Orthopedics, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China. Electronic address: .
Pokaż więcej
Źródło:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Jan; Vol. 157, pp. 113985. Date of Electronic Publication: 2022 Nov 16.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Depression*/drug therapy
Neoplasm Recurrence, Local*/drug therapy
Humans ; Antidepressive Agents/pharmacology ; Antidepressive Agents/therapeutic use ; Tumor Microenvironment
Czasopismo naukowe
Szczegóły
Tytuł:
Pretreatment Serum Lactate Dehydrogenase and Metastases Numbers as Potential Determinants of Anti-PD-1 Therapy Outcome in Nasopharyngeal Carcinoma.
Autorzy:
Ali WAS; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
Huang X; Department of Endoscopy, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
Wu Y; Department of Clinical Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
Ma Y; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
Pan H; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
Liao J; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
Yang Z; Department of Clinical Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
Hong S; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
Yang Y; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
Huang Y; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
Zhao Y; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
Fang W; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
Zhao H; Department of Clinical Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
Zhang L; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 71067Sun Yat-sen University Cancer Center, Guangzhou, China.
Pokaż więcej
Źródło:
Cancer control : journal of the Moffitt Cancer Center [Cancer Control] 2023 Jan-Dec; Vol. 30, pp. 10732748221148912.
Typ publikacji:
Journal Article
MeSH Terms:
Nasopharyngeal Neoplasms*/drug therapy
Neoplasm Recurrence, Local*
Humans ; Lactate Dehydrogenases ; Nasopharyngeal Carcinoma/drug therapy ; Prognosis ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Szczegóły
Tytuł:
Comparing the efficacy of salvage regimens for relapsed/refractory B-cell acute lymphoblastic leukaemia: a systematic review and network meta-analysis.
Autorzy:
Cao HY; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Wan CL; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Xue SL; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China. .; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China. .
Pokaż więcej
Źródło:
Annals of hematology [Ann Hematol] 2023 Jan; Vol. 102 (1), pp. 155-165. Date of Electronic Publication: 2022 Nov 17.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy
Humans ; Inotuzumab Ozogamicin/therapeutic use ; Network Meta-Analysis ; Remission Induction ; Antigens, CD19
Czasopismo naukowe
Szczegóły
Tytuł:
The relative importance of treatment outcomes to surgeons' recommendations for low-risk thyroid cancer.
Autorzy:
Chiu AS; Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI. Electronic address: .
Saucke MC; Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI.
Bushaw K; Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI.
Voils CI; Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI.
Sydnor J; University of Wisconsin School of Business, Madison, WI.
Haymart M; Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MI.
Pitt SC; Department of Surgery, University of Michigan School of Medicine, Ann Arbor, MI.
Pokaż więcej
Źródło:
Surgery [Surgery] 2023 Jan; Vol. 173 (1), pp. 183-188. Date of Electronic Publication: 2022 Sep 29.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/surgery
Thyroid Neoplasms*/surgery
Humans ; Middle Aged ; Cross-Sectional Studies ; Thyroidectomy/methods ; Treatment Outcome
Czasopismo naukowe
Szczegóły
Tytuł:
The emerging therapeutic landscape of relapsed/refractory multiple myeloma.
Autorzy:
Tanenbaum B; Department of Medicine, UMass Chan Medical School, UMass Memorial Medical Center, 55 Lake Ave. North, Worcester, MA, 01655, USA.
Miett T; Department of Medicine, UMass Chan Medical School, UMass Memorial Medical Center, 55 Lake Ave. North, Worcester, MA, 01655, USA.
Patel SA; Department of Medicine - Division of Hematology/Oncology, UMass Chan Medical School, UMass Memorial Medical Center, 55 Lake Ave. North, Worcester, MA, 01655, USA. .; Center for Clinical and Translational Science (CCTS), UMass Chan Medical School, 55 Lake Ave. North, Worcester, MA, 01655, USA. .
Pokaż więcej
Źródło:
Annals of hematology [Ann Hematol] 2023 Jan; Vol. 102 (1), pp. 1-11. Date of Electronic Publication: 2022 Dec 03.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Multiple Myeloma*/drug therapy
Neoplasm Recurrence, Local*/drug therapy
Aged ; Humans ; Antibodies, Bispecific/therapeutic use ; Antibodies, Monoclonal/therapeutic use ; Antineoplastic Agents/therapeutic use ; B-Cell Maturation Antigen/therapeutic use ; Immunotherapy, Adoptive ; Clinical Trials as Topic
Czasopismo naukowe
Szczegóły
Tytuł:
Clinical practice guidelines for the management of recurrent head and neck cancer: a systematic review and quality appraisal.
Autorzy:
De Ravin E; Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, 800 Walnut Street, 18th Floor, Philadelphia, PA, 19107, USA.; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Lu J; Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
Salmon M; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Venkatesh S; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Romeo D; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Moreira A; Department of Pediatrics, University of Texas Health-San Antonio, San Antonio, TX, USA.
Rajasekaran K; Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, 800 Walnut Street, 18th Floor, Philadelphia, PA, 19107, USA. .; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA. .
Pokaż więcej
Źródło:
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery [Eur Arch Otorhinolaryngol] 2023 Jan; Vol. 280 (1), pp. 297-305. Date of Electronic Publication: 2022 Aug 12.
Typ publikacji:
Systematic Review; Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/therapy
Head and Neck Neoplasms*/therapy
Humans ; Databases, Factual
Czasopismo naukowe
Szczegóły
Tytuł:
Hemoglobin, albumin, lymphocyte, and platelet (HALP) score and cancer prognosis: A systematic review and meta-analysis of 13,110 patients.
Autorzy:
Xu H; Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
Zheng X; Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
Ai J; Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. Electronic address: .
Yang L; Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. Electronic address: .
Pokaż więcej
Źródło:
International immunopharmacology [Int Immunopharmacol] 2023 Jan; Vol. 114, pp. 109496. Date of Electronic Publication: 2022 Nov 30.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Biomarkers, Tumor*
Neoplasm Recurrence, Local*
Humans ; Prognosis ; Albumins ; Lymphocytes ; Hemoglobins
Czasopismo naukowe
Szczegóły
Tytuł:
Safety and antitumor activity of copanlisib in Japanese patients with relapsed/refractory indolent non-Hodgkin lymphoma: a phase Ib/II study.
Autorzy:
Fukuhara N; Department of Hematology, Tohoku University Hospital, Sendai, 980-8574, Japan. .
Maruyama D; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Hatake K; Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Nagai H; Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
Makita S; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Kamezaki K; Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Uchida T; Department of Hematology and Oncology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.
Kusumoto S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Kuroda J; Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Iriyama C; Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
Yanada M; Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
Tsukamoto N; Department of Medicine and Clinical Science, Gunma University Hospital, Gunma, Japan.
Suehiro Y; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Minami H; Department of Medical Oncology/Hematology, Kobe University Hospital, Kobe, Japan.
Garcia-Vargas J; Bayer HealthCare Pharmaceuticals, Inc, Whippany, NJ, USA.
Childs BH; Bayer HealthCare Pharmaceuticals, Inc, Whippany, NJ, USA.
Yasuda M; Bayer Yakuhin, Ltd, Osaka, Japan.
Masuda S; Bayer Yakuhin, Ltd, Osaka, Japan.
Tsujino T; Bayer Yakuhin, Ltd, Osaka, Japan.
Terao Y; Bayer Yakuhin, Ltd, Osaka, Japan.
Tobinai K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Pokaż więcej
Źródło:
International journal of hematology [Int J Hematol] 2023 Jan; Vol. 117 (1), pp. 100-109. Date of Electronic Publication: 2022 Sep 29.
Typ publikacji:
Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
MeSH Terms:
Lymphoma, Non-Hodgkin*/drug therapy
Lymphoma, Non-Hodgkin*/pathology
Neoplasm Recurrence, Local*/drug therapy
Quinazolines*/adverse effects
Humans ; Antineoplastic Agents/adverse effects
Czasopismo naukowe
Szczegóły
Tytuł:
Focal pancreatic ductal change induced by 10-Fr S-type plastic stent in chronic pancreatitis.
Autorzy:
Takuma K; Division of Gastroenterology and Hepatology, Toho University Omori Medical Center, Tokyo, Japan.
Okano N; Division of Gastroenterology and Hepatology, Toho University Omori Medical Center, Tokyo, Japan.
Ito K; Division of Gastroenterology and Hepatology, Toho University Omori Medical Center, Tokyo, Japan.
Ujita W; Division of Gastroenterology and Hepatology, Toho University Omori Medical Center, Tokyo, Japan.
Iwata S; Division of Gastroenterology and Hepatology, Toho University Omori Medical Center, Tokyo, Japan.
Mizutani S; Division of Gastroenterology and Hepatology, Toho University Omori Medical Center, Tokyo, Japan.
Nakagawa H; Division of Gastroenterology and Hepatology, Toho University Omori Medical Center, Tokyo, Japan.
Watanabe K; Division of Gastroenterology and Hepatology, Toho University Omori Medical Center, Tokyo, Japan.
Yamada Y; Division of Gastroenterology and Hepatology, Toho University Omori Medical Center, Tokyo, Japan.
Kimura Y; Division of Gastroenterology and Hepatology, Toho University Omori Medical Center, Tokyo, Japan.
Yoshimoto K; Division of Gastroenterology and Hepatology, Toho University Omori Medical Center, Tokyo, Japan.
Iwasaki S; Division of Gastroenterology and Hepatology, Toho University Omori Medical Center, Tokyo, Japan.
Hara S; Division of Gastroenterology and Hepatology, Toho University Omori Medical Center, Tokyo, Japan.
Kishimoto Y; Division of Gastroenterology and Hepatology, Toho University Omori Medical Center, Tokyo, Japan.
Igarashi Y; Division of Gastroenterology and Hepatology, Toho University Omori Medical Center, Tokyo, Japan.
Matsuda T; Division of Gastroenterology and Hepatology, Toho University Omori Medical Center, Tokyo, Japan.
Amemiya K; Department of Surgical Pathology, Toho University Omori Medical Center, Tokyo, Japan.
Pokaż więcej
Źródło:
Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2023 Jan; Vol. 38 (1), pp. 112-118. Date of Electronic Publication: 2022 Nov 16.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/complications
Pancreatitis, Chronic*/surgery
Pancreatitis, Chronic*/complications
Humans ; Retrospective Studies ; Pancreatic Ducts/surgery ; Stents/adverse effects ; Plastics ; Cholangiopancreatography, Endoscopic Retrograde
Czasopismo naukowe
Szczegóły
Tytuł:
Letter to the editor "Extramural venous invasion (EMVI) in colorectal cancer is associated with increased cancer recurrence and cancer-related death".
Autorzy:
Zou M; Department of Colorectal and Anal Surgery, The 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Lanzhou, 730050, Gansu Province, China.
Yang ZQ; Department of Colorectal Surgery, Gansu Provincial Central Hospital, Lanzhou, 730070, Gansu Province, China.
Gao F; Department of Colorectal and Anal Surgery, The 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Lanzhou, 730050, Gansu Province, China. Electronic address: .
Pokaż więcej
Źródło:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2023 Jan; Vol. 49 (1), pp. 298-299. Date of Electronic Publication: 2022 Aug 19.
Typ publikacji:
Letter
MeSH Terms:
Neoplasm Recurrence, Local*
Rectal Neoplasms*
Humans ; Prognosis ; Neoplasm Invasiveness ; Magnetic Resonance Imaging ; Retrospective Studies
Opinia redakcyjna
Szczegóły
Wyświetlanie 1-20 z 61614

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz